Ministry of Health of Belarus registered vitamin drug Neurolec
At the turn of September Ministry of Health of the Republic of Belarus registered Neurolec, a new vitamin drug manufactured by Minskintercaps.
One capsule composition:
Thiamine mononitrate (Vitamin B1) 51.75 mg
Riboflavin (Vitamin B2) 25.95 mg
Pyridoxine hydrochloride (Vitamin B6) 10.35 mg
Ascorbic acid (Vitamin C) 181.75 mg
Calcium pantothenate (Vitamin B5) 25.95 mg
Folic acid (Vitamin B9) 0.52 mg
Nicotinamide (Vitamin B3) 103.75 mg
Cyanocobalamin (Vitamin B12) 5 µg
Neurolec is administered for treatment of neurological disorders caused by demonstrated deficiency of Vitamin B group deficiency that can be eliminated by diet correction.
Neurolec can be recommended to patients with complaints like burning, numbness, pain, gooseflesh on hands and legs (diabetic, alcohol, dysmetabolic polyneuropathy), in recovery period after nerve injuries, radiculitis, and radicular syndrome recovery stage.
The drug is on sale starting with December, 2019.